Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Dexamethasone in Non-Hypoxic COVID-19
NCT04836780Phase 3Unknown
- Sponsor
- Hospital Universitario Infanta Leonor
- Start
- Jun 2021
- Primary completion
- Feb 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in COVID-19 pneumonia comparing Dexamethasone with Standard of care (2 arms). Primary endpoint: Development of moderate-severe Acute Respiratory Distress Syndrome at 7 days. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04836780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04836780.